ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Copenhagen
State: Hovedstaden
Zip:
Country: Denmark
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2023 | Series A | $0 |
Gilde Healthcare HealthCap Novo Holdings Pontifax RA Capital Management Ysios Capital Gilde Healthcare HealthCap Novo Holdings Pontifax RA Capital Management Ysios Capital Gilde Healthcare HealthCap Novo Holdings Pontifax RA Capital Management Ysios Capital Gilde Healthcare HealthCap Novo Holdings Pontifax RA Capital Management Ysios Capital |
4/2021 | Series A | 5 | $61.8M |
Gilde Healthcare HealthCap Novo Holdings RA Capital Management Ysios Capital Gilde Healthcare HealthCap Novo Holdings RA Capital Management Ysios Capital |
8/2019 | Debt Financing | $1.5M | 1/2018 | Grant | 1 | - |
Novo Nordisk Foundation Novo Nordisk Foundation Novo Nordisk Foundation Novo Nordisk Foundation |
1/2018 | Grant | 1 | - |
Novo Nordisk Foundation Novo Nordisk Foundation Novo Nordisk Foundation Novo Nordisk Foundation |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|